Diabetes occurs when blood sugar levels remain elevated over time. Pancreas produces insufficient insulin to transport glucose to cells. High blood sugar levels are known as hyperglycemia
Linagliptin is used with diet and exercise for type 2 diabetes. Not approved for type 1 diabetes treatment. Available as 5 mg oral tablet under brand name Tradjenta
Ozempic (semaglutide) treats type 2 diabetes and reduces cardiovascular risk. Works by increasing insulin production and slowing food digestion. FDA-approved for diabetes control and cardiovascular protection
MOUNJARO improves glycemic control in type 2 diabetes mellitus. Starting dose is 2.5 mg weekly subcutaneously. Maximum dose is 15 mg weekly subcutaneously. Should be injected in abdomen, thigh, or upper arm
Both drugs are GLP-1 agonists used to treat type 2 diabetes. Both are given weekly subcutaneous injections under skin. Both cost about $930-935 monthly
LADA combines features of both type 1 and type 2 diabetes. Disease develops slowly over at least six months. Patients show insulin resistance similar to type 2 diabetes. Often misdiagnosed as type 2 diabetes